Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Medical Properties Trust is a reit-healthcare facilities business based in the US. Medical Properties Trust shares (MPW) are listed on the NYSE and all prices are listed in US Dollars. Medical Properties Trust employs 112 staff and has a trailing 12-month revenue of around $1.6 billion.
Finder Award
SoFi Invest
Finder Award
eToro
Robinhood
| Latest market close | $12.79 |
|---|---|
| 52-week range | $9.67 - $20.59 |
| 50-day moving average | $12.33 |
| 200-day moving average | $14.43 |
| Wall St. target price | $15.38 |
| PE ratio | 6.1866 |
| Dividend yield | $1.15 (8.88%) |
| Earnings per share (TTM) | $2.09 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $12.79 from 2023-02-03
| 1 week (2023-01-30) | 0.24% |
|---|---|
| 1 month (2023-01-05) | 6.67% |
| 3 months (2022-11-03) | 15.23% |
| 6 months (2022-08-03) | N/A |
| 1 year (2022-02-07) | -40.40% |
|---|---|
| 2 years (2021-02-05) | -39.99% |
| 3 years (2020-02-07) | 20.9281 |
| 5 years (2018-02-07) | 41.91% |
Valuing Medical Properties Trust stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medical Properties Trust's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Medical Properties Trust's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 6x. In other words, Medical Properties Trust shares trade at around 6x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Medical Properties Trust's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.93. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Medical Properties Trust's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Medical Properties Trust's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.3 billion.
The EBITDA is a measure of a Medical Properties Trust's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $1.6 billion |
|---|---|
| Operating margin TTM | 58.91% |
| Gross profit TTM | $1.5 billion |
| Return on assets TTM | 3.06% |
| Return on equity TTM | 14.55% |
| Profit margin | 77.51% |
| Book value | $14.75 |
| Market capitalisation | $7.7 billion |
TTM: trailing 12 months
Dividend payout ratio: 66.67% of net profits
Recently Medical Properties Trust has paid out, on average, around 66.67% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 8.88% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Medical Properties Trust shareholders could enjoy a 8.88% return on their shares, in the form of dividend payments. In Medical Properties Trust's case, that would currently equate to about $1.15 per share.
Medical Properties Trust's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Medical Properties Trust's most recent dividend payout was on 11 January 2023. The latest dividend was paid out to all shareholders who bought their shares by 6 December 2022 (the "ex-dividend date").
Over the last 12 months, Medical Properties Trust's shares have ranged in value from as little as $9.6709 up to $20.5882. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Medical Properties Trust's is 0.9365. This would suggest that Medical Properties Trust's shares are less volatile than average (for this exchange).
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 431 facilities and roughly 43,000 licensed beds in nine countries and across four continents on a pro forma basis. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. .
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.